Effect of cisapride on plasma levels of motilin, gastrin, somatostatin and secretin in man

Pharmacy and Pharmacology Communications

Volumn 6, Issue 12, 2000, Pages 533-538

  Itoh, H ^a   Nagano, T ^a   Takeyama, M ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; GASTRIN; MOTILIN; MUSCARINIC M1 RECEPTOR; PIRENZEPINE; SECRETIN; SOMATOSTATIN;

ADULT; ARTICLE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG POTENTIATION; ELECTROIMMUNOASSAY; GASTRIN BLOOD LEVEL; GASTROINTESTINAL MOTILITY; HUMAN; HUMAN EXPERIMENT; MALE; SECRETIN BLOOD LEVEL; SOMATOSTATIN BLOOD LEVEL;

EID: 0034511923     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cisapride: A gastrointestinal prokinetic drug
2. Presence of a gastric motor-stimulating property in duodenal extracts
3. Plasma secretin concentrations in fasting and postprandial state in man
4. Motilin
5. Determination of cisapride and norcisapride in human plasma using high-performance liquid chromatography with ultraviolet detection
6. On the chemical mechanism of gastric secretion
7. Cholinergic control mechanisms for immunoreactive motilin release and motility in the canine duodenum
8. 2 (Pirenzepin) beim menschen
9. Effect of cisapride on gastric and esophageal emptying in insulindependent diabetes mellitus
10. Motilin-induced mechanical activity in the canine alimentary tract
11. Enzyme immunoassay secretin-like immunoreactive substance in human plasma
12. On the biological activity and amino acid composition of secretin
13. Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy
14. 14C-pirenzepine in rats
15. Effect of cisapride on gastric emptying and ileal transit time of balanced liquid meal in healthy subjects
16. M1-muscarinic mechanisms regulate interdigestive cycling of motor and secretory activity in human upper gut
17. Somatostatin: Some aspects of its physiology and pathophysiology
18. Facilitation and inhibition by 5-hydroxytriptamine and R51619 of acetylcholine release from guinea-pig myenteric neurones
19. Cholinergic regulation of motilin release from isolated canine intestinal cells
20. Colon motility and colo-anal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride
21. Development and clinical use of the new gastrointestinal prokinetic drug cisapride (R51619)
22. Immuno-fluorescent reactivity to anti-somatostatin in the gastrointestinal mucosa of the dog
23. Stimulating effects of cisapride on antroduodenal motility in the conscious dog
24. Effect of cisapride and renzapride on gastrointestinal motility and plasma motilin concentration in dogs
25. Pirenzepine-sensitive muscarinic receptors regulate gastric somatostatin and gastrin
26. Enzyme immunoassay of somatostatin (SS)-like immunoreactive substance in bovine milk
27. Enzyme immunoassay of gastrin in human plasma
28. Enzyme immunoassay of motilin in human plasma
29. Effectiveness of cisapride in gastric ulcer. Results of a double-blind randomized trial versus ranitidine and versus cisapride plus ranitidine
30. Gastrointestinal motility stimulating properties of cisapride, a non-antidopaminergic, non-cholinergic compound
31. Gastrin
32. Muscarinic control of phase III concentrations and motilin release in dogs
33. Studies on plasma motilin concentration and interdigestive motility of the duodenum in humans